One-third of people living with HIV in Latvia have experienced discrimination due to their HIV status, according to the initial HIV Stigma Index results.

Tahmina Khaidarova is the Director of the Tajikistan Network of Women Living with HIV (TNW Plus). Daniil Kashnitskyi, ECUO Program Advisor, took an interview with her.

Researchers argue that interventions are urgently needed to reach older adults and Hispanics to address HIV testing and beliefs.

Given globalization and other social phenomena, controlling the spread of infectious diseases has become an imperative public health priority.

Call for Membership (2018 – 2020) to the Developing Country NGO Delegation to the Board of The Global Fund to Fight AIDS, Tuberculosis and Malaria

This app provides mobile access to WHO PrEP Implementation Tool (WHO Implementation Tool for Pre-Exposure Prophylaxis of HIV Infection) and was developed to be a “digital pocket reference” available for clinicians and pharmacists. WHO has developed a series of modules to support the implementation of PrEP ...

Gilead announces new data on the impact of Truvada® (emtricitabine and tenofovir disoproxil fumarate) for pre-exposure prophylaxis (PrEP) on the number of HIV diagnoses in the United States.

Merck announces week 96 data from pivotal Phase 3 drive-forward study of its investigational HIV therapy doravirine.

Scientists from UNSW Sydney and the UK have discovered that the human immunodeficiency virus (HIV) hijacks a small molecule from the host cell to protect itself from being destroyed by the host's immune system.

The mosaic Ad26/Ad26 plus gp140 HIV-1 vaccine induced comparable and robust immune responses in humans and rhesus monkeys, and it provided significant protection against repetitive heterologous SHIV challenges in rhesus monkeys. This vaccine concept is currently being evaluated in a phase 2b clinical efficacy study ...

Interview with Dr. Arash Alaei, consultant and Director of the International Institute for Health and Education

An experimental vaccine for HIV is set to be tried on humans in 2019.

Fear of others thinking they’re promiscuous, or that they’re already infected with HIV, is a barrier to many women who might benefit from pills that help prevent the infection, a U.S. study suggests.

Last December, Ministry of Social Affairs and National Institute for Health Development from Estonia, WHO European Region, UNAIDS and the Global Fund organised a two day meeting on challenges and opportunities in national HIV and TB programmes management.

On May 15, an exhibition "The Color of Blood – Fire, Love and Life" was opened in the Art Salon of the Poltava Regional Organization of the National Union of Artists of Ukraine. The exhibition participants tried to draw public attention to the problems of ...

18 stories of people from different regions of Belarus living with HIV and successfully taking antiretroviral therapy.

Taking large numbers of medications in addition to antiretroviral therapy (ART) is associated with an increased risk of hospitalisation and death for HIV-positive individuals, investigators from the US Department of Veterans Affairs report in AIDS.

On May 18, Kazakhstan will host a nationwide action dedicated to the World Remembrance Day of AIDS Victims. The action starts at 11.00 in the Republican AIDS Center, Almaty, after which it will spread to all regions of the country in order to attract the ...